Literature DB >> 17308354

Molecular and cellular immune mediators of neuroprotection.

Nicolas P Turrin1, Serge Rivest.   

Abstract

Our view of the immune privileged status of the brain has dramatically changed during the past two decades. Even though systemic immune stimuli have the ability to activate different populations of neurons, cells of monocytic lineage also have access to the neuronal tissue and populate it as microglia. Although such a phenomenon is limited in intact brains, it is greatly increased during neurodegenerative processes associated with innate immunity and the release of pro-inflammatory molecules by either resident microglia or those derived from the bone marrow stem cells. The role of these events is currently a matter of great debate and controversy, especially as it relates to brain protection, repair, or further injury. In recent years, accumulating data have supported the notion that when immune molecules are timely released by microglia, they limit neuronal injury in the presence of pathogens and toxic agents, help clear debris from degenerated cells, and restore the cerebral environment for repair. It has been shown that alteration of the natural innate immune response by microglia has direct consequences in exacerbating the damages following acute injury to neurons. This article presents and discusses these data, supporting a powerful neuroprotective role for microglia and their innate immune reactions in response to pathogens and central nervous system insults.

Entities:  

Mesh:

Year:  2006        PMID: 17308354     DOI: 10.1385/MN:34:3:221

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  101 in total

1.  Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment.

Authors:  J Priller; A Flügel; T Wehner; M Boentert; C A Haas; M Prinz; F Fernández-Klett; K Prass; I Bechmann; B A de Boer; M Frotscher; G W Kreutzberg; D A Persons; U Dirnagl
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

2.  Androgens are neuroprotective in the dentate gyrus of adrenalectomized female rats.

Authors:  C A Frye; C M McCormick
Journal:  Stress       Date:  2000-05       Impact factor: 3.493

3.  Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.

Authors:  Myreille D'Astous; Pablo Mendez; Marc Morissette; Luis Miguel Garcia-Segura; Thérèse Di Paolo
Journal:  Mol Pharmacol       Date:  2006-01-24       Impact factor: 4.436

4.  Neurotrophin-based strategies for neuroprotection.

Authors:  Frank M Longo; Stephen M Massa
Journal:  J Alzheimers Dis       Date:  2004-12       Impact factor: 4.472

Review 5.  Autophagy in neurodegenerative disease: friend, foe or turncoat?

Authors:  Ralph A Nixon
Journal:  Trends Neurosci       Date:  2006-07-20       Impact factor: 13.837

6.  Neurotrophins protect against cytosine arabinoside-induced apoptosis of immature rat cerebellar neurons.

Authors:  P Leeds; Y Leng; E Chalecka-Franaszek; D-M Chuang
Journal:  Neurochem Int       Date:  2005-01       Impact factor: 3.921

7.  High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients.

Authors:  T Qian; X Guo; A D Levi; S Vanni; R T Shebert; M L Sipski
Journal:  Spinal Cord       Date:  2005-04       Impact factor: 2.772

8.  Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease.

Authors:  Iwona Kurkowska-Jastrzebska; Tomasz Litwin; Ilona Joniec; Agnieszka Ciesielska; Adam Przybyłkowski; Andrzej Członkowski; Anna Członkowska
Journal:  Int Immunopharmacol       Date:  2004-10       Impact factor: 4.932

9.  NGF acts via p75 low-affinity neurotrophin receptor and calpain inhibition to reduce UV neurotoxicity.

Authors:  Adrian T McCollum; Steven Estus
Journal:  J Neurosci Res       Date:  2004-08-15       Impact factor: 4.164

10.  Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

Authors:  Louise McCullough; Liejun Wu; Norman Haughey; Xibin Liang; Tracey Hand; Qian Wang; Richard M Breyer; Katrin Andreasson
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

View more
  30 in total

1.  Gold ions bio-released from metallic gold particles reduce inflammation and apoptosis and increase the regenerative responses in focal brain injury.

Authors:  Agnete Larsen; Kristian Kolind; Dan Sonne Pedersen; Peter Doering; Mie Ostergaard Pedersen; Gorm Danscher; Milena Penkowa; Meredin Stoltenberg
Journal:  Histochem Cell Biol       Date:  2008-06-10       Impact factor: 4.304

Review 2.  Microglial phenotype and adaptation.

Authors:  B J L Eggen; D Raj; U-K Hanisch; H W G M Boddeke
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

3.  Morphine preconditioning protects against LPS-induced neuroinflammation and memory deficit.

Authors:  Farzaneh Rostami; Shahrbanoo Oryan; Abolhassan Ahmadiani; Leila Dargahi
Journal:  J Mol Neurosci       Date:  2012-03-03       Impact factor: 3.444

4.  Translating concepts of neural repair after stroke: Structural and functional targets for recovery.

Authors:  Robert W Regenhardt; Hajime Takase; Eng H Lo; David J Lin
Journal:  Restor Neurol Neurosci       Date:  2020       Impact factor: 2.406

5.  TNF-α and Microglial Hormetic Involvement in Neurological Health & Migraine.

Authors:  Richard P Kraig; Heidi M Mitchell; Barbara Christie-Pope; Phillip E Kunkler; David M White; Ya-Ping Tang; George Langan
Journal:  Dose Response       Date:  2010-02-18       Impact factor: 2.658

6.  Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection.

Authors:  Rick B Meeker; Winona Poulton; Silva Markovic-Plese; Colin Hall; Kevin Robertson
Journal:  J Neurovirol       Date:  2011-05-10       Impact factor: 2.643

Review 7.  Pathological and protective roles of glia in chronic pain.

Authors:  Erin D Milligan; Linda R Watkins
Journal:  Nat Rev Neurosci       Date:  2009-01       Impact factor: 34.870

Review 8.  Spinal cord injury: time to move?

Authors:  Serge Rossignol; Martin Schwab; Michal Schwartz; Michael G Fehlings
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

Review 9.  Inhibition of microglia activation as a phenotypic assay in early drug discovery.

Authors:  Mariana Figuera-Losada; Camilo Rojas; Barbara S Slusher
Journal:  J Biomol Screen       Date:  2013-08-14

10.  RNase L mediated protection from virus induced demyelination.

Authors:  Derek D C Ireland; Stephen A Stohlman; David R Hinton; Parul Kapil; Robert H Silverman; Roscoe A Atkinson; Cornelia C Bergmann
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.